Tag: Alcohol use disorder
-
Ozempic sober: Could GLP-1 meds dull alcohol intoxication and aid AUD treatment?
What is the new finding about GLP-1 medications and alcohol? Recent early research has sparked interest in whether GLP-1 receptor agonists — including popular drugs like Ozempic (semaglutide) — can change how the body handles alcohol. In a pilot study with adults who are overweight or obese, researchers observed a slower rise in blood alcohol…
-
Ozempic Sober: What GLP-1 Medications Could Mean for Alcohol Intoxication
What “Ozempic sober” means Recent research has sparked discussion about a possible new effect of GLP-1 receptor agonists, a class of drugs that includes Ozempic (semaglutide). The term “Ozempic sober” has surfaced in media coverage to describe a potential change in how the body processes and experiences alcohol while on these medications. Early signals from…
-
Ozempic and Alcohol: Could GLP-1 Medications Alter How We Feel Intoxicated?
What the new findings suggest Recent work from the Fralin Biomedical Research Institute at Virginia Tech explored whether GLP-1 receptor agonists—drugs like semaglutide, the active ingredient in Ozempic and Wegovy—might change how the body processes alcohol. In a small pilot study involving 20 participants with obesity, researchers gave participants a measured alcoholic beverage designed to…
-
Wegovy and Ozempic Could Help Alcohol Dependence: Early Findings
Background Wegovy and Ozempic are brand names for semaglutide, a GLP‑1 receptor agonist. While they are primarily used for obesity management and type 2 diabetes, researchers are beginning to explore whether these drugs might influence alcohol use disorders as well. In a small US study, investigators observed that some participants reduced their alcohol consumption while…
-
Semaglutide Could Aid Alcohol Dependence: Wegovy & Ozempic
New clues on semaglutide and alcohol dependence In recent years, semaglutide, the active ingredient in Wegovy and Ozempic, has drawn attention beyond weight loss and diabetes management. A small American study provides the first clinical hints that this GLP-1 receptor agonist could help people with alcohol use disorder by reducing the amount they drink during…